Health Health วันนี้ Health ล่าสุด | Page 117 of 127

Gore REDUCE Clinical Study Five-Year Results Demonstrate That PFO Closure With The GORE® CARDIOFORM Septal Occluder Provides Safe Long-Term Reduction Of Recurrent Stroke

– Published in the New England Journal of Medicine (NEJM), the REDUCE Study continues to show the largest reduction in recurrent ischemic stroke in all PFO shunt sizes over medical therapy alone.*,¹ – Long-term results highlight GORE® CARDIOFORM Septal Occluder can be trusted for patient safety and effective defect closure. W. L. Gore & Associates (Gore), today […]

Health 12 มี.ค. 64 9:00

thaipr.net

12 มี.ค. 64

Baxter, a global leader in Dialysis Care, reaffirms its commitment to equitable access to care on World Kidney Day

Baxter, a global leader in dialysis care, is proud to support this year’s World Kidney Day, under the theme “Living Well with Kidney Disease“. Kidney disease affects approximately 10% of the global population, and in Thailand, 11.6 million (17.5%) people currently have chronic kidney disease, 5.7 million (8.6%) have end-stage renal disease (ESRD) (stages 3–5), and over […]

Health 11 มี.ค. 64 8:30

thaipr.net

11 มี.ค. 64

Understanding Spinal Muscular Atrophy: SMA The rare disease found in children, still awaiting hope

A rare disease, as defined by the Thai Ministry of Public Health, is any disease that affects a small percentage of the population – precisely, less than 10,000 people in the country. With only…

Health 5 มี.ค. 64 13:262021-03-05

thaipr.net

5 มี.ค. 64

MedAlliance Receives Fourth FDA Breakthrough Device Designation for Sirolimus Drug-Eluting Balloon in Treatment of De Novo Coronary Lesions

MedAlliance, the first drug-eluting balloon (DEB) company in the world to receive US Food and Drug Administration (FDA) Breakthrough Device Designation Status for a sirolimus DEB, has now been awarded breakthrough status for SELUTION SLR™, its sustained limus release DEB catheter, in the treatment of atherosclerotic lesions in native coronary arteries. This is the fourth breakthrough […]

Health 4 มี.ค. 64 14:40

thaipr.net

4 มี.ค. 64

Medical expert warns thousands could die from HPV programming interrupted by Covid-19

On HPV Awareness Day, the International Papillomavirus Society is urging women to attend delayed cervical screenings and for all interrupted services to re-start as thousands continue to miss out on vital HPV care, with deadly consequences. The IPVS is also calling for global vaccine equity. One woman dies from cervical cancer every 2 minutes but HPV […]

Health 4 มี.ค. 64 9:302021-03-04

thaipr.net

4 มี.ค. 64

Cipla receives final approval for generic version of GlaxoSmithKline’s IMITREX® (Sumatriptan Nasal Spray, 20 mg)

Cipla Limited (BSE: 500087) (NSE: CIPLA EQ) (hereinafter referred to as “Cipla”) today announced that it has received final approval for its Abbreviated New Drug Application (ANDA) for Sumatriptan Nasal Spray, 20 mg from the United States Food and Drug Administration (U.S. FDA). Cipla’s Sumatriptan Nasal Spray USP, 20 mg is an AB-rated generic therapeutic […]

Health 3 มี.ค. 64 11:40

thaipr.net

3 มี.ค. 64

COVID-19 Vaccine AstraZeneca in Final Stage of Ensuring Highest Quality Assurance for Thailand

AstraZeneca is deeply committed to supporting the Government of Thailand’s efforts to stem the pandemic through timely access to the COVID-19 Vaccine AstraZeneca. The shipment of COVID-19 Vaccine…

Health 1 มี.ค. 64 10:36

thaipr.net

1 มี.ค. 64

New Data Presented at ACTRIMS Forum 2021 Indicate MAVENCLAD®-treated RMS Patients Mount Protective Antibody Response to Common Vaccines

MAGNIFY-MS retrospective analysis demonstrates patients develop protective antibody levels for at least six months following seasonal influenza and varicella zoster vaccines, irrespective of vaccine timing relative to MAVENCLAD dosing Initial findings from the CLOCK-MS vaccine sub-study show protective influenza antibody levels at four weeks post-vaccination in MS patients taking MAVENCLAD In both studies, protective antibody […]

Health 1 มี.ค. 64 8:08

thaipr.net

1 มี.ค. 64

Think You’ve Been Harmed by Products Containing Talc? Your Rights May Be Affected and Your Injury Claims May Be Eliminated. Your Vote Will Help Determine How Injury Claims are Treated

Submit Your Vote by March 25, 2021. The following statement is being issued by Prime Clerk LLC regarding the Imerys Chapter 11. If you have a Talc Personal Injury Claim, your rights are affected by an upcoming vote on a plan of reorganization (the “Plan”) as part of the chapter 11 proceedings of Imerys Talc […]

Health 1 มี.ค. 64 8:00

thaipr.net

1 มี.ค. 64

Occlutech announces Completion of Patient Enrolment in Pilot Study of Atrial Flow Regulator (AFR) in Patients with Heart Failure

Occlutech, a privately-held company, announced today the completion of patient enrolment in its pilot study to assess safety and efficacy of the novel Atrial Flow Regulator (AFR) in heart failure (HF) patients (PRELIEVE trial). PRELIEVE is a prospective, multicenter, open-label, non-randomized pilot study that evaluates the results of AFR implantation in patients with either heart […]

Health 25 ก.พ. 64 17:35

thaipr.net

25 ก.พ. 64